InsidersTradesSigma
Total declarations
Company
▲ Purchases (8 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
8
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-2.7%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Lebovits Chaim, Chairman & CEO. Director active across 1 company, notably Brainstorm Cell Therapeutics INC.. In total, 22 disclosures have been published. Split: 8 buys · 0 sell. Total volume traded: €178k. History available since 10 December 2021. The latest transaction was filed on 26 February 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Lebovits Chaim
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations22 total
1,800,000 shares0Common StockSEC:0001104659-26-068339:0
120,000 shares0Common StockSEC:0001104659-25-000895:0
22,000 shares@ US$0.2281.3% of flowCommon StockSEC:0001104659-24-105215:0
Canonical exit: 29 Dec 2024 (T+90)
130,000 shares@ US$0.545719.0% of flowCommon StockSEC:0001104659-24-084334:0
Canonical exit: 16 Jul 2024 (T+90)
25,000 shares@ US$0.5793.8% of flowCommon StockSEC:0001104659-24-084343:0
Canonical exit: 19 Aug 2024 (T+90)
135,000 shares@ US$0.375313.4% of flowCommon StockSEC:0001104659-24-084337:0
Canonical exit: 4 Aug 2024 (T+90)
15,000 shares@ US$0.51832.0% of flowCommon StockSEC:0001104659-24-084344:0
Canonical exit: 26 Aug 2024 (T+90)
20,000 shares@ US$0.4652.5% of flowCommon StockSEC:0001104659-24-084341:0
Canonical exit: 8 Aug 2024 (T+90)
15,000 shares@ US$0.51992.1% of flowCommon StockSEC:0001104659-24-084336:0
Canonical exit: 18 Jul 2024 (T+90)
66,300 shares@ US$0.37436.6% of flowCommon StockSEC:0001104659-24-084339:0
Canonical exit: 5 Aug 2024 (T+90)
15,000 shares@ US$0.51832.0% of flowCommon StockSEC:0001104659-24-067529:0
25,000 shares@ US$0.5793.8% of flowCommon StockSEC:0001104659-24-064415:0
20,000 shares@ US$0.4652.5% of flowCommon StockSEC:0001104659-24-060889:0
66,300 shares@ US$0.37436.6% of flowCommon StockSEC:0001104659-24-058218:0
135,000 shares@ US$0.375313.4% of flowCommon StockSEC:0001104659-24-057784:0
15,000 shares@ US$0.51992.1% of flowCommon StockSEC:0001104659-24-051948:0
130,000 shares@ US$0.545719.0% of flowCommon StockSEC:0001104659-24-049027:0
305,198 shares0Common StockSEC:0001104659-24-034091:0
31,185 shares0Common StockSEC:0001104659-23-087819:0
75,000 shares0Common StockSEC:0001104659-23-048639:0
31,185 shares0Common StockSEC:0001104659-23-000634:0
31,185 shares0Common StockSEC:0001104659-21-148753:0
22 of 22 declarations
About Lebovits Chaim
Lebovits Chaim is Président-Directeur Général and, according to the 22 filings recorded, has been associated with Brainstorm Cell Therapeutics INC. over the period from 2021-12-10 to 2026-05-29. In the sampled recent filings, purchases total EUR 177580, sales are EUR 0, and the most frequent transaction nature is Attribution.
